Iddm30 controls pancreatic expression of Ccl11 (Eotaxin) and the Th1/Th2 balance within the insulitic lesions

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3645-3653

  Chao, Gary Y C ^a,b   Wallis, Robert H ^a   Marandi, Leili ^a   Ning, Terri ^a   Sarmiento, Janice ^a,b   Paterson, Andrew D ^c   Poussier, Philippe ^a,b  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BREEDING; CHEMOKINE CCL11; DIABETES MELLITUS, TYPE 1; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETIC LOCI; GENOTYPE; HUMANS; INSULIN-SECRETING CELLS; MALE; PANCREAS; PHENOTYPE; RATS; RATS, INBRED BB; TH1-TH2 BALANCE; TRANSCRIPTION, GENETIC;

EID: 84898652114     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302383     Document Type: Article

References (52)

1. Mordes, J. P., R. Bortell, J. Doukas, M. Rigby, B. Whalen, D. Zipris, D. L. Greiner, and A. A. Rossini. 1996. The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes Metab. Rev. 12: 103-109.
2. Wallis, R. H., K. Wang, L. Marandi, E. Hsieh, T. Ning, G. Y. Chao, J. Sarmiento, A. D. Paterson, and P. Poussier. 2009. Type 1 diabetes in the BB rat: a polygenic disease. Diabetes 58: 1007-1017.
3. Jacob, H. J., A. Pettersson, D. Wilson, Y. Mao, A. Lernmark, and E. S. Lander. 1992. Genetic dissection of autoimmune type I diabetes in the BB rat. Nat. Genet. 2: 56-60.
4. Like, A. A., C. A. Biron, E. J. Weringer, K. Byman, E. Sroczynski, and D. L. Guberski. 1986. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J. Exp. Med. 164: 1145-1159.
5. Colle, E., A. Fuks, P. Poussier, P. Edouard, and R. D. Guttmann. 1992. Polygenic nature of spontaneous diabetes in the rat: permissive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility. Diabetes 41: 1617-1623.
6. Edouard, P., J. C. Hiserodt, C. Plamondon, and P. Poussier. 1993. CD8+ T-cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes 42: 390-397.
7. Métroz-Dayer, M. D., A. Mouland, C. Brideau, D. Duhamel, and P. Poussier. 1990. Adoptive transfer of diabetes in BB rats induced by CD4 T lymphocytes. Diabetes 39: 928-932.
8. Chao, N. J., L. Timmerman, H. O. McDevitt, and C. O. Jacob. 1989. Molecular characterization of MHC class II antigens (beta 1 domain) in the BB diabetesprone and -resistant rat. Immunogenetics 29: 231-234.
9. Colle, E., R. D. Guttmann, and T. Seemayer. 1981. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J. Exp. Med. 154: 1237-1242.
10. Guttmann, R. D., E. Colle, F. Michel, and T. Seemayer. 1983. Spontaneous diabetes mellitus syndrome in the rat. II. T lymphopenia and its association with clinical disease and pancreatic lymphocytic infiltration. J. Immunol. 130: 1732-1735.
11. Poussier, P., A. F. Nakhooda, J. A. Falk, C. Lee, and E. B. Marliss. 1982. Lymphopenia and abnormal lymphocyte subsets in the "BB" rat: relationship to the diabetic syndrome. Endocrinology 110: 1825-1827.
12. Angelillo, M., D. L. Greiner, J. P. Mordes, E. S. Handler, N. Nakamura, U. McKeever, and A. Rossini. 1988. Absence of RT6+ T cells in diabetes-prone biobreeding/Worcester rats is due to genetic and cell developmental defects. J. Immunol. 141: 4146-4151.
13. Woda, B. A., A. A. Like, C. Padden, and M. L. McFadden. 1986. Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J. Immunol. 136: 856-859.
14. Markholst, H., S. Eastman, D. Wilson, B. E. Andreasen, and A. Lernmark. 1991. Diabetes segregates as a single locus in crosses between inbred BB rats prone or resistant to diabetes. J. Exp. Med. 174: 297-300.
15. Poussier, P., T. Ning, T. Murphy, D. Dabrowski, and S. Ramanathan. 2005. Impaired post-thymic development of regulatory CD4+25+ T cells contributes to diabetes pathogenesis in BB rats. J. Immunol. 174: 4081-4089.
16. Wallis, R. H., K. Wang, D. Dabrowski, L. Marandi, T. Ning, E. Hsieh, A. D. Paterson, J. P. Mordes, E. P. Blankenhorn, and P. Poussier. 2007. A novel susceptibility locus on rat chromosome 8 affects spontaneous but not experimentally induced type 1 diabetes. Diabetes 56: 1731-1736.
17. Fuller, J. M., M. Bogdani, T. D. Tupling, R. A. Jensen, R. Pefley, S. Manavi, L. Cort, E. P. Blankenhorn, J. P. Mordes, A. Lernmark, and A. E. Kwitek. 2009. Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene. Physiol. Genomics 38: 89-97.
18. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670-6675.
19. Fox, C. J., and J. S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158: 2414-2424.
20. Fox, C. J., and J. S. Danska. 1998. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 47: 331-338.
21. Fox, C. J., A. D. Paterson, S. M. Mortin-Toth, and J. S. Danska. 2000. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am. J. Hum. Genet. 67: 67-81.
22. MacMurray, A. J., D. H. Moralejo, A. E. Kwitek, E. A. Rutledge, B. Van Yserloo, P. Gohlke, S. J. Speros, B. Snyder, J. Schaefer, S. Bieg, et al. 2002. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res. 12: 1029-1039.
23. Hornum, L., J. Rømer, and H. Markholst. 2002. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes 51: 1972-1979.
24. Hessner, M. J., X. Wang, L. Meyer, R. Geoffrey, S. Jia, J. Fuller, A. Lernmark, and S. Ghosh. 2004. Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. J. Immunol. 173: 6993-7002.
25. Carvalho-Pinto, C., M. I. García, L. Gómez, A. Ballesteros, A. Zaballos, J. M. Flores, M. Mellado, J. M. Rodríguez-Frade, D. Balomenos, and C. Martínez-A. 2004. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur. J. Immunol. 34: 548-557.
26. Schulte, B. M., K. H. Lanke, J. D. Piganelli, E. D. Kers-Rebel, R. Bottino, M. Trucco, R. J. Huijbens, T. R. Radstake, M. A. Engelse, E. J. de Koning, et al. 2012. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 61: 2030-2036.
27. Ribaux, P., J. A. Ehses, N. Lin-Marq, F. Carrozzino, M. Böni-Schnetzler, E. Hammar, J. C. Irminger, M. Y. Donath, and P. A. Halban. 2007. Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic beta-cells. Endocrinology 148: 5582-5590.
28. Forssmann, U., M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185: 2171-2176.
29. Kitaura, M., N. Suzuki, T. Imai, S. Takagi, R. Suzuki, T. Nakajima, K. Hirai, H. Nomiyama, and O. Yoshie. 1999. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J. Biol. Chem. 274: 27975-27980.
30. Ponath, P. D., S. Qin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97: 604-612.
31. White, J. R., C. Imburgia, E. Dul, E. Appelbaum, K. O'Donnell, D. J. O'Shannessy, M. Brawner, J. Fornwald, J. Adamou, N. A. Elshourbagy, et al. 1997. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Leukoc. Biol. 62: 667-675.
32. Humbles, A. A., B. Lu, D. S. Friend, S. Okinaga, J. Lora, A. Al-Garawi, T. R. Martin, N. P. Gerard, and C. Gerard. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA 99: 1479-1484.
33. Gutierrez-Ramos, J. C., C. Lloyd, and J. A. Gonzalo. 1999. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol. Today 20: 500-504.
34. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
35. Eastman, S., H. Markholst, D. Wilson, and A. Lernmark. 1991. Leukocytosis at the onset of diabetes in crosses of inbred BB rats. Diabetes Res. Clin. Pract. 12: 113-123.
36. Kurner, T., V. Burkart, and H. Kolb. 1986. Large increase of cytotoxic/suppressor T-lymphoblasts and eosinophils around manifestation of diabetes in BB rats. Diabetes Res. 3: 349-353.
37. Geoffrey, R., S. Jia, A. E. Kwitek, J. Woodliff, S. Ghosh, A. Lernmark, X. Wang, and M. J. Hessner. 2006. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J. Immunol. 177: 7275-7286.
38. Bradley, L. M., V. C. Asensio, L. K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162: 2511-2520.
39. Zipris, D. 1996. Evidence that Th1 lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat. J. Autoimmun. 9: 315-319.
40. Rabinovitch, A., W. Suarez-Pinzon, A. El-Sheikh, O. Sorensen, and R. F. Power. 1996. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes 45: 749-754.
41. Pipeleers, D. G., and M. A. Pipeleers-Marichal. 1981. A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 20: 654-663.
42. Ricordi, C., D. W. Gray, B. J. Hering, D. B. Kaufman, G. L. Warnock, N. M. Kneteman, S. P. Lake, N. J. London, C. Socci, R. Alejandro, et al. 1990. Islet isolation assessment in man and large animals. Acta Diabetol. Lat. 27: 185-195.
43. Mathieu, C., K. Casteels, M. Waer, J. Laureys, D. Valckx, and R. Bouillon. 1998. Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2. Transplant. Proc. 30: 541.
44. Qin, H. Y., and B. Singh. 1997. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 10: 271-278.
45. Fulkerson, P. C., C. A. Fischetti, M. L. McBride, L. M. Hassman, S. P. Hogan, and M. E. Rothenberg. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc. Natl. Acad. Sci. USA 103: 16418-16423.
46. Huang, X., B. Hultgren, N. Dybdal, and T. A. Stewart. 1994. Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1: 469-478.
47. Ono, S. J., B. Issa-Chergui, E. Colle, R. D. Guttmann, T. A. Seemayer, and A. Fuks. 1988. IDDM in BB rats: enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes 37: 1411-1418.
48. Wang, G. S., J. Karamchandani, O. Pulido, L. Rosenberg, and F. W. Scott. 2002. Altered islet homeostasis before classic insulitis in BB rats. Diabetes Metab. 28: 3S90-3S97; discussion 3S108-3S112.
49. Hammar, E. B., J. C. Irminger, K. Rickenbach, G. Parnaud, P. Ribaux, D. Bosco, D. G. Rouiller, and P. A. Halban. 2005. Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J. Biol. Chem. 280: 30630-30637.
50. Matsukura, S., C. Stellato, J. R. Plitt, C. Bickel, K. Miura, S. N. Georas, V. Casolaro, and R. P. Schleimer. 1999. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J. Immunol. 163: 6876-6883.
51. Tomkinson, A., C. Duez, G. Cieslewicz, and E. W. Gelfand. 2001. Eotaxin-1-deficient mice develop airway eosinophilia and airway hyperresponsiveness. Int. Arch. Allergy Immunol. 126: 119-125.
52. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87-99.